Asia Pacific Fetal Bovine Serum Market Size & Outlook
Asia Pacific fetal bovine serum market, 2018-2030 (US$M)
Related Markets
Asia Pacific fetal bovine serum market highlights
- The Asia Pacific fetal bovine serum market generated a revenue of USD 408.6 million in 2023.
- The market is expected to grow at a CAGR of 15.6% from 2024 to 2030.
- In terms of segment, cell-based research was the largest revenue generating application in 2023.
- In-vitro fertilization is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 408.6 million |
| Market revenue in 2030 | USD 1,127.9 million |
| Growth rate | 15.6% (CAGR from 2023 to 2030) |
| Largest segment | Cell-based research |
| Fastest growing segment | In-vitro fertilization |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Drug Discovery, In-vitro fertilization, Vaccine production, Cell-based research, Diagnostics |
| Key market players worldwide | Thermo Fisher Scientific Inc, Sartorius AG, Danaher Corp, Merck KGaA, HiMedia Laboratories, Bio-Techne Corp, PAN-Biotech GmbH, Atlas Biologicals, Inc., RMBIO, Biowest |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 22.5% of the global fetal bovine serum market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,127.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Fetal Bovine Serum Market Scope
Fetal Bovine Serum Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific fetal bovine serum market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fetal bovine serum market will help companies and investors design strategic landscapes.
Cell-based research was the largest segment with a revenue share of 29.37% in 2023. Horizon Databook has segmented the Asia Pacific fetal bovine serum market based on drug discovery, in-vitro fertilization, vaccine production, cell-based research, diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.
- Asia Pacific Fetal Bovine Serum Application Outlook (Revenue, USD Million, 2018-2030)
- Drug Discovery
- In-vitro fertilization
- Vaccine production
- Cell-based research
- Diagnostics
- Others
- Asia Pacific Fetal Bovine Serum End-user Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical & biotechnology companies
- Contract Research Organizations (CRO)
- Academic and research organizations
- Others
Reasons to subscribe to Asia Pacific fetal bovine serum market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific fetal bovine serum market databook
-
Our clientele includes a mix of fetal bovine serum market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific fetal bovine serum market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific fetal bovine serum market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific fetal bovine serum market outlook size, by country, 2018-2030 (US$M)
Asia Pacific Fetal Bovine Serum Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
